Published in Fertil Steril on March 27, 2011
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev (2012) 2.22
Genetics of the polycystic ovary syndrome. Mol Cell Endocrinol (2012) 0.97
Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes. Acta Diabetol (2012) 0.89
Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS). PLoS One (2013) 0.86
Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids (2011) 0.83
Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity. J Clin Endocrinol Metab (2016) 0.81
Genetics of polycystic ovary syndrome. Semin Reprod Med (2014) 0.81
Association of type 2 diabetes mellitus genes in polycystic ovary syndrome aetiology among women from southern India. Indian J Med Res (2016) 0.75
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet (1993) 51.42
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (2007) 43.16
A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature (2007) 35.08
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06
A general test of association for quantitative traits in nuclear families. Am J Hum Genet (2000) 22.45
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet (2006) 19.03
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics (2003) 17.92
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet (2000) 15.19
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet (2007) 13.28
The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab (2004) 7.96
Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet (2009) 5.43
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab (1999) 5.28
Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet (2007) 3.58
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A (1998) 2.86
Whole-genome genotyping. Methods Enzymol (2006) 2.16
Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J Clin Endocrinol Metab (2005) 1.84
Whole-genome genotyping of haplotype tag single nucleotide polymorphisms. Pharmacogenomics (2006) 1.60
Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab (1996) 1.49
Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations. Diabetes (2002) 1.37
Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J Clin Endocrinol Metab (2009) 1.17
Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab (2001) 1.11
Insulin resistance in polycystic ovary syndrome: progress and paradoxes. Recent Prog Horm Res (2001) 1.06
Type 2 diabetes and the polycystic ovary syndrome. Minerva Ginecol (2004) 0.92
Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS. Diabetologia (2007) 0.88
Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels. Eur J Hum Genet (2007) 0.81
Genetic contributions to glucose intolerance in polycystic ovary syndrome. Reprod Biomed Online (2004) 0.77
Genetic analysis of genome-wide variation in human gene expression. Nature (2004) 27.28
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Mapping determinants of human gene expression by regional and genome-wide association. Nature (2005) 17.24
Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet (2003) 11.63
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
The genetics of variation in gene expression. Nat Genet (2002) 4.83
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
Genetics of human gene expression: mapping DNA variants that influence gene expression. Nat Rev Genet (2009) 4.05
Derivation of oocytes from mouse embryonic stem cells. Science (2003) 4.03
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 3.80
Polycystic ovary syndrome. Lancet (2007) 3.62
Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab (2006) 3.46
Inflammation and pregnancy. Reprod Sci (2009) 3.33
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril (2004) 3.03
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol (2011) 3.02
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol (2004) 2.60
Absence of secretory endometrium after false-positive home urine luteinizing hormone testing. Fertil Steril (2004) 2.59
Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet (2010) 2.51
Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab (2005) 2.50
Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. Gastroenterology (2010) 2.45
Polymorphic cis- and trans-regulation of human gene expression. PLoS Biol (2010) 2.42
Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab (2002) 2.40
Genetic analysis of radiation-induced changes in human gene expression. Nature (2009) 2.30
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 2.28
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev (2012) 2.22
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature (2008) 2.09
Effects of cis and trans genetic ancestry on gene expression in African Americans. PLoS Genet (2008) 2.09
A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes (2011) 2.09
Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol (2008) 1.92
Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 1.90
Diminished paternity and gonadal function with increasing obesity in men. Fertil Steril (2008) 1.90
Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.84
Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril (2005) 1.82
Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice. J Clin Invest (2011) 1.81
A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A (2004) 1.79
Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study. Diabetes (2008) 1.78
Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril (2006) 1.75
Coexpression network based on natural variation in human gene expression reveals gene interactions and functions. Genome Res (2009) 1.74
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab (2002) 1.67
Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility. N Engl J Med (2015) 1.65
Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab (2008) 1.65
The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr (2008) 1.63
Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab (2002) 1.63
Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol (2012) 1.62
Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab (2003) 1.60
The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem (2003) 1.59
Health disparities in risk for cervical insufficiency. Hum Reprod (2010) 1.58
Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab (2006) 1.56
CRTC3 links catecholamine signalling to energy balance. Nature (2010) 1.55
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril (2002) 1.55
Population structure of Hispanics in the United States: the multi-ethnic study of atherosclerosis. PLoS Genet (2012) 1.53
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrate. Fertil Steril (2003) 1.51
Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab (2006) 1.51
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet (2011) 1.51
A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet (2013) 1.50
The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS. J Clin Endocrinol Metab (2013) 1.50
Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome. Fertil Steril (2008) 1.49
Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab (2002) 1.47
Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 1.44
Continuous glucose monitoring during pregnancy in women with polycystic ovary syndrome. Obstet Gynecol (2011) 1.42
A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem (2001) 1.42
NIH funding reform. Science (2005) 1.41
The Hirsute woman: challenges in evaluation and management. Endocr Pract (2011) 1.41
Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question. Maturitas (2010) 1.39
Fifteen-year trend in the use of male reproductive surgery: analysis of the healthcare cost and utilization project data. BJU Int (2011) 1.39
Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome. Proc Natl Acad Sci U S A (2006) 1.38
Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome. Mol Cell Endocrinol (2011) 1.38
Genetic contributions to disparities in preterm birth. Pediatr Res (2009) 1.37
Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J Clin Endocrinol Metab (2007) 1.37